Literature DB >> 15930427

TAC--a new standard in adjuvant therapy for breast cancer?

Edith A Perez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930427     DOI: 10.1056/NEJMe058056

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.

Authors:  Lara E Sucheston-Campbell; Alyssa I Clay-Gilmour; William E Barlow; G Thomas Budd; Daniel O Stram; Christopher A Haiman; Xin Sheng; Li Yan; Gary Zirpoli; Song Yao; Chen Jiang; Kouros Owzar; Dawn Hershman; Kathy S Albain; Daniel F Hayes; Halle C Moore; Timothy J Hobday; James A Stewart; Abbas Rizvi; Claudine Isaacs; Muhammad Salim; Jule R Gralow; Gabriel N Hortobagyi; Robert B Livingston; Deanna L Kroetz; Christine B Ambrosone
Journal:  Pharmacogenet Genomics       Date:  2018-02       Impact factor: 2.089

2.  Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).

Authors:  Lara E Sucheston; Hua Zhao; Song Yao; Gary Zirpoli; Song Liu; William E Barlow; Halle C F Moore; G Thomas Budd; Dawn L Hershman; Warren Davis; Gregory L Ciupak; James A Stewart; Claudine Isaacs; Timothy J Hobday; Muhammad Salim; Gabriel N Hortobagyi; Julie R Gralow; Robert B Livingston; Kathy S Albain; Daniel F Hayes; Christine B Ambrosone
Journal:  Breast Cancer Res Treat       Date:  2011-07-16       Impact factor: 4.872

3.  Influence of the Sense of Coherence, the Doctor-Patient Relationship, Optimism and Non-Haematological Adverse Reactions on Health-Related Quality of Life in Patients with Breast Cancer.

Authors:  Blanca Prieto-Callejero; Francisco Rivera; Montserrat Andrés-Villas; Juan Gómez-Salgado
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

4.  Recent advances in adjuvant systemic treatment for breast cancer: all systems go!

Authors:  P N Fishman; S Verma
Journal:  Curr Oncol       Date:  2006-10       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.